Paclitol 260mg Injection

Overview Paclitol 260mg Injection

Oncaspar (260mg injectable formulation) is a chemotherapeutic agent indicated in the management of breast, pancreatic, and non-small cell lung cancers. Administration is strictly intravenous, performed by a healthcare professional. Dosage and frequency are determined individually by your oncologist, depending on your specific cancer and response to treatment, and may be adjusted. Adhere precisely to the prescribed regimen; incorrect usage or overdose can lead to severe adverse events. Therapeutic benefits might not be apparent for weeks or months; discontinue only under your doctor's guidance. Common side effects include nausea, emesis, and fatigue. Serious adverse reactions, such as peripheral edema, alopecia, weight increase, and others may occur. Concomitant medications may mitigate some side effects; however, report any unusual bruising or bleeding, pharyngitis, oral ulcers, or fever immediately. This drug can suppress bone marrow function, potentially increasing infection risk. Regular blood counts and liver function tests are mandatory. Prior to initiating therapy, disclose any existing cardiovascular, hepatic, or renal conditions, as well as all current medications, especially anti-infectives, to your physician. Drug interactions are possible; a comprehensive medication review is crucial. This medication is contraindicated in pregnancy and lactation; reliable contraception is essential for both partners during treatment.

Primary Ingredients of Paclitol 260mg Injection

No text was provided to rewrite.

Uses of Paclitol 260mg Injection

Cancers affecting the breast, lungs (non-small cell type), and pancreas.

Major Benefits of Paclitol 260mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

Common Side effects of Paclitol 260mg Injection:

• Nausea
• Vomiting
• Weakness
• Low blood platelets
• Rash
• Upper respiratory tract infection
• Urinary tract infection
• Bleeding
• Anemia (low number of red blood cells)
• Flushing (sense of warmth in the face, ears, neck and trunk)
• Hair loss
• Decreased blood pressure
• Peripheral neuropathy (tingling and numbness of feet and hand)
• Diarrhea
• Decreased white blood cell count (neutrophils)

How to use Paclitol 260mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Paclitol 260mg Injection works:

Oncaspar (260mg injection) is a cancer treatment that disrupts microtubule function, essential for cancer cell division and proliferation. This action inhibits tumor growth, ultimately leading to cancer cell death.

What if you forget to take Paclitol 260mg Injection :

NA